| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.099 | 0.05 |